Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

REPEAT: UK Earnings, Trading Statements Calendar - Week Ahead

Mon, 09th Mar 2015 16:01

UK Earnings, Trading Statements Calendar 
Tuesday, March 10 
John MenziesFull Year Results
Close BrothersHalf Year Results
Hill & Smith HoldingsFull Year Results
Ocado GroupQ1 Trading Statement
BangoFull Year Results
Cairn EnergyFull Year Results
G4SFull Year Results
Esure GroupFull Year Results
InchcapeFull Year Results
St IvesHalf Year Results
Matomy Media GroupFull Year Results
TymanFull Year Results
CranewareHalf Year Results
StatPro Group Full Year Results
Kalibrate TechnologiesHalf Year Results
SDLFull Year Results
PrudentialFull Year Results at 0815 GMT
Goals Soccer CentresFull Year Results
Wednesday, March 11 
Centaur MediaFull Year Results
N BrownTrading Statement
BWINFull Year Results
FoxtonsFull Year Results
Brooks MacdonaldHalf Year Results
HikmaFull Year Results
Servelec GroupFull Year Results
Modern WaterFull Year Results
Michael Page InternationalFull Year Results
Ceres Power Holdings Half Year Results
FDM GroupFull Year Results
Boohoo.comTrading Statement
Thursday, March 12 
Cineworld GroupFull Year Results
LSL PropertyFull Year Results
Wm Morrison SupermarketsFull Year Results
ComputacenterTrading Statement
Home Retail GroupTrading Statement
SIGFull Year Results
TT ElectronicsFull Year Results
ASOSTrading Statement
Stock Spirits GroupFull Year Results
Cambridge Cognition HoldingsFull Year Results
SOCO InternationalFull Year Results
Friday, March 13 
JD WetherspoonHalf Year Results
SthreeQ1 Interim Management Statement
Oxford BiomedicaFull Year Results
Independent News & MediaFull Year Results 
Monday, March 16 
Tribal GroupFull Year Results
Real Estate Investors Full Year Results
EKF Diagnostics HoldingsFull Year Results
BradyFull Year Results
Smart Metering SystemsFull Year Results
Petards GroupFull Year Results
  
Copyright 2015 Alliance News Limited. All Rights Reserved.
  

More News
28 Jan 2022 19:17

UPDATE: Oxford BioMedica raises GBP80 million via placing

UPDATE: Oxford BioMedica raises GBP80 million via placing

Read more
28 Jan 2022 16:59

LONDON MARKET CLOSE: Stocks close out rollercoaster week with losses

LONDON MARKET CLOSE: Stocks close out rollercoaster week with losses

Read more
28 Jan 2022 16:19

CORRECT: Oxford BioMedica to acquire 80% ownership of new US business

CORRECT: Oxford BioMedica to acquire 80% ownership of new US business

Read more
28 Jan 2022 12:13

LONDON MARKET MIDDAY: Stocks sink on Ukraine tensions and hawkish Fed

LONDON MARKET MIDDAY: Stocks sink on Ukraine tensions and hawkish Fed

Read more
28 Jan 2022 10:27

Oxford BioMedica to acquire 80% ownership of new US virus business

Oxford BioMedica to acquire 80% ownership of new US virus business

Read more
28 Jan 2022 09:56

Oxford Biomedica creates venture with Homology, launches £80m fundraise

(Sharecast News) - Cell and gene therapy specialist Oxford Biomedica announced an agreement with Homology Medicines on Friday, as well as a placing to raise £80m from new and existing shareholders, including a retail offer through the PrimaryBid platform.

Read more
17 Jan 2022 09:32

Oxford Biomedica starts search for new CEO as Dawson steps down

Oxford Biomedica starts search for new CEO as Dawson steps down

Read more
17 Jan 2022 07:10

Oxford Biomedica CEO John Dawson to step down

(Sharecast News) - Oxford Biomedica chief executive John Dawson said he was stepping down after 13 years at the helm of the Gene and cell therapy firm which helped develop a Covid-19 vaccine with AstraZeneca.

Read more
5 Jan 2022 08:54

Oxford Biomedica wins new agreement for LentiVector platform

Oxford Biomedica wins new agreement for LentiVector platform

Read more
5 Jan 2022 07:29

Oxford Biomedica signs licence, supply deal with Cabaletta Bio

(Sharecast News) - Gene and cell therapy group Oxford Biomedica on Wednesday said it had signed a new license and supply agreement on its LentiVector platform with US-based Cabaletta Bio.

Read more
15 Dec 2021 09:33

LONDON BROKER RATINGS: BofA starts Pod Point at Buy; Barclays cuts DCC

LONDON BROKER RATINGS: BofA starts Pod Point at Buy; Barclays cuts DCC

Read more
13 Dec 2021 10:03

Oxford Biomedica in license and supply deals with Novartis and Arcellx

Oxford Biomedica in license and supply deals with Novartis and Arcellx

Read more
13 Dec 2021 07:31

Oxford Biomedica strikes new license and supply agreements

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has struck new license and supply agreements for its lentiviral vectors.

Read more
19 Oct 2021 10:50

Oxford BioMedica licences technology for cystic fibrosis treatment

Oxford BioMedica licences technology for cystic fibrosis treatment

Read more
19 Oct 2021 09:18

Boehringer Ingelheim licenses Oxford Biomedica's lentiviral vector technology

(Sharecast News) - Gene and cell therapy firm Oxford Biomedica said on Tuesday that pharmaceutical giant Boehringer Ingelheim had exercised its option to license its lentiviral vector technology to manufacture, register and commercialise a treatment for cystic fibrosis.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.